XML 48 R33.htm IDEA: XBRL DOCUMENT v3.19.1
Earnings Per Common Share Attributable to Common Shareholders (Tables)
 3 Months Ended
Mar. 31, 2019
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earning Per Share
The following table provides the detailed calculation of EPS:
 
 
Three Months Ended
(IN MILLIONS)
 
March 31,
2019

 
April 1,
2018

EPS Numerator––Basic
 
 
 
 
Income from continuing operations
 
$
3,889

 
$
3,571

Less: Net income attributable to noncontrolling interests
 
6

 
9

Income from continuing operations attributable to Pfizer Inc.
 
3,884

 
3,562

Less: Preferred stock dividends––net of tax
 
—

 
—

Income from continuing operations attributable to Pfizer Inc. common shareholders
 
3,883

 
3,562

Discontinued operations––net of tax
 
—

 
(1
)
Net income attributable to Pfizer Inc. common shareholders
 
$
3,883

 
$
3,560

EPS Numerator––Diluted
 
 

 
 

Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions
 
$
3,884

 
$
3,562

Discontinued operations––net of tax, attributable to Pfizer Inc. common shareholders and assumed conversions
 
—

 
(1
)
Net income attributable to Pfizer Inc. common shareholders and assumed conversions
 
$
3,884

 
$
3,561

EPS Denominator
 
 

 
 

Weighted-average number of common shares outstanding––Basic
 
5,635

 
5,957

Common-share equivalents: stock options, stock issuable under employee compensation plans, convertible preferred stock and accelerated share repurchase agreements
 
115

 
100

Weighted-average number of common shares outstanding––Diluted
 
5,750

 
6,057

Stock options that had exercise prices greater than the average market price of our common stock issuable under employee compensation plans(a)
 
2

 
2

Cash dividends declared per share
 
$
0.36

 
$
0.34

(a) 
These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.